Erratum to CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space [Angiogenesis, DOI 10.1007/s10456-014-9454-1];CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space

Angiogenesis

Volumn 18, Issue 2, 2015, Pages 163-171

  Vries, Mark H M ^a   Wagenaar, Allard ^a   Verbruggen, Sanne E L ^a   Molin, Daniel G M ^a   Post, Mark J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Arteriogenesis; Chemokines; Endothelial cells; Monocytes; Peripheral vascular disease

Indexed keywords

CD68 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; MESSENGER RNA; CXCL1 PROTEIN, RAT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTERY PERFUSION; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL POPULATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMORAL ARTERY; FLUORESCENCE ACTIVATED CELL SORTING; HINDLIMB; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; LEUKOCYTE COUNT; MALE; MONOCYTE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHEAR STRESS; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTERY; CELL CULTURE; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; MUSCLE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; ARTERIES; CELLS, CULTURED; CHEMOKINE CXCL1; MALE; MUSCLE CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-8B; RNA, MESSENGER;

EID: 84925511996     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-014-9458-x     Document Type: Erratum

References (37)

1. Schaper W, Schaper J (2004) Arteriogenesis. Kluwer Academic Publishers Group, Boston
2. Heil M, Eitenmuller I, Schmitz-Rixen T, Schaper W (2006) Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 10:45–55
3. Vogel R, Traupe T, Steiger VS, Seiler C (2010) Physical coronary arteriogenesis: a human “model” of collateral growth promotion. Trends Cardiovasc Med 20:129–133
4. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685–693
5. Schirmer SH, van Nooijen FC, Piek JJ, van Royen N (2009) Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart 95:191–197
6. Hoefer IE, Grundmann S, van Royen N, Voskuil M, Schirmer SH, Ulusans S, Bode C, Buschmann IR, Piek JJ (2005) Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes. Atherosclerosis 181:285–293
7. Takeda Y, Costa S, Delamarre E, Roncal C, de Oliveira RL, Squadrito ML, Finisguerra V, Deschoemaeker S, Bruyere F, Wenes M, Hamm A, Serneels J, Magat J, Bhattacharyya T, Anisimov A, Jordan BF, Alitalo K, Maxwell P, Gallez B, Zhuang ZW, Saito Y, Simons M, De Palma M, Mazzone M (2011) Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479:122–126
8. Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165:5269–5277
9. Hagiwara H, Mitsumata M, Yamane T, Jin X, Yoshida Y (1998) Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. Circulation 98:2584–2590
10. Bozic CR, Gerard NP, von Uexkull-Guldenband C, Kolakowski LF Jr, Conklyn MJ, Breslow R, Showell HJ, Gerard C (1994) The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem 269:29355–29358
11. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273:10095–10098
12. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W (1997) Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80:829–837
13. Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, Schaper W (2002) Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 34:775–787
14. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964
15. Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, Richmond A, Strieter R, Dey SK, DuBois RN (2006) CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 203:941–951
16. Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, Norton L, Brogi E, Massague J (2012) A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150:165–178
17. Payne AS, Cornelius LA (2002) The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 118:915–922
18. Kuo PL, Shen KH, Hung SH, Hsu YL (2012) CXCL1/GROalpha increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-kappaB/HDAC1 epigenetic regulation. Carcinogenesis 33:2477–2487
19. Breland UM, Halvorsen B, Hol J, Oie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Froland SS, Haraldsen G, Gullestad L, Damas JK, Hansson GK, Aukrust P (2008) A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol 28:1005–1011
20. Huo Y, Weber C, Forlow SB, Sperandio M, Thatte J, Mack M, Jung S, Littman DR, Ley K (2001) The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest 108:1307–1314
21. Zhou Z, Subramanian P, Sevilmis G, Globke B, Soehnlein O, Karshovska E, Megens R, Heyll K, Chun J, Saulnier-Blache JS, Reinholz M, van Zandvoort M, Weber C, Schober A (2011) Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab 13:592–600
22. Manoharan P, Basford JE, Pilcher-Roberts R, Neumann J, Hui DY, Lingrel JB (2014) Reduced levels of microRNAs miR-124a and miR-150 are associated with increased proinflammatory mediator expression in Krüppel-like factor 2 (KLF2)-deficient macrophages. J Biol Chem 289:31638–31646
23. Smith DF, Galkina E, Ley K, Huo Y (2005) GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol 289:H1976–H1984
24. Kuo YT, Jan RL, Kuo CH, Kuo PL, Wang WL, Huang MY, Chen HN, Hung CH (2012) Effects of vitamin D3 on the expression of GROalpha in THP-1 cells and human primary monocytes. J Food Sci 77:H47–H52
25. Arisaka T, Mitsumata M, Kawasumi M, Tohjima T, Hirose S, Yoshida Y (1995) Effects of shear stress on glycosaminoglycan synthesis in vascular endothelial cells. Ann N Y Acad Sci 748:543–554
26. Gouverneur M, Spaan JA, Pannekoek H, Fontijn RD, Vink H (2006) Fluid shear stress stimulates incorporation of hyaluronan into endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 290:H458–H462
27. Grundmann S, Schirmer SH, Hekking LH, Post JA, Ionita MG, de Groot D, van Royen N, van den Berg B, Vink H, Moser M, Bode C, de Kleijn D, Pasterkamp G, Piek JJ, Hoefer IE (2009) Endothelial glycocalyx dimensions are reduced in growing collateral arteries and modulate leucocyte adhesion in arteriogenesis. J Cell Mol Med 13:3463–3474
28. Mantovani A, Bonecchi R, Locati M (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6:907–918
29. Poluri KM, Joseph PR, Sawant KV, Rajarathnam K (2013) Molecular basis of glycosaminoglycan heparin binding to chemokine CXCL1 dimer. J Biol Chem 288:25143–25153
30. Meen AJ, Oynebraten I, Reine TM, Duelli A, Svennevig K, Pejler G, Jenssen T, Kolset SO (2010) Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J Biol Chem 286:2636–2647
31. Whittall C, Kehoe O, King S, Rot A, Patterson A, Middleton J (2013) A chemokine self-presentation mechanism involving formation of endothelial surface microstructures. J Immunol 190:1725–1736
32. Schaper J, Konig R, Franz D, Schaper W (1976) The endothelial surface of growing coronary collateral arteries. Intimal margination and diapedesis of monocytes. A combined SEM and TEM study. Virchows Arch A Pathol Anat Histol 370:193–205
33. Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311–317
34. Jetten N, Donners MM, Wagenaar A, Cleutjens JP, van Rooijen N, de Winther MP, Post MJ (2013) Local delivery of polarized macrophages improves reperfusion recovery in a mouse hind limb ischemia model. PLoS ONE 8:e68811
35. Braber S, Overbeek SA, Koelink PJ, Henricks PA, Zaman GJ, Garssen J, Kraneveld AD, Folkerts G (2011) CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1. Eur J Pharmacol 668:443–449
36. Shireman PK (2007) The chemokine system in arteriogenesis and hind limb ischemia. J Vasc Surg 45(Suppl A):A48–A56
37. Martin D, Galisteo R, Gutkind JS (2009) CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 284:6038–6042